PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in USZacks Investment Research • 11/22/24
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The SidelinesSeeking Alpha • 11/20/24
Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.Business Wire • 11/20/24
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 MoreZacks Investment Research • 11/12/24
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View UpZacks Investment Research • 11/12/24
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' ContinuesInvestors Business Daily • 11/08/24
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/07/24
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)Business Wire • 11/07/24
Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 11/04/24
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in NovemberBusiness Wire • 11/01/24
Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 OthersZacks Investment Research • 10/21/24